In a report released today, Tim Anderson from Bank of America Securities reiterated a Sell rating on Amgen (AMGN – Research Report), with a ...

Amgen Inc . (NASDAQ:AMGN), a leading biotechnology company with a market capitalization of $151.3 billion, is navigating a ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions ...

Citi lowered the firm’s price target on Amgen (AMGN) to $295 from $310 and keeps a Neutral rating on the shares. Ahead of the Q4 earnings, the ...

Today, Benzinga 's options scanner spotted 28 uncommon options trades for Amgen. This isn't normal. The overall sentiment of ...

The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of ...

Avior Wealth Management LLC trimmed its stake in Amgen Inc. (NASDAQ:AMGN – Free Report) by 49.8% during the fourth quarter, ...

The five stocks at the bottom of the barrel, which pulled down the winners, were in fact, losers. Not only were they the tail ...

U.S. markets closed out a strong week, with the S&P 500 (SP500) posting its first record closing high of 2025. Read more ...

Equities research analysts at William Blair reduced their FY2024 earnings per share estimates for shares of Amgen in a ...

The pharmaceutical industry could generate more than $1.2 trillion in global sales in 2025, according to Statista. The cancer segment alone is expected to generate $208 billion in sales this year. The ...